RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Celecoxib Cross Trial Safety Analysis
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 2
SP 15
OP 16
DO 10.1177/155989770800800213
UL http://mdc.sagepub.com/content/8/2/15.2.abstract
AB Long-term use of celecoxib is associated with an increase in cardiovascular (CV) risk for some patients, according to findings from a pooled analysis of 6 placebo-controlled, randomized clinical trials. The degree of risk is associated with both baseline CV risk and celecoxib dose.